Samir Rashmikant Patel serves as Executive at Akari Therapeutics Plc, where they oversee executive responsibilities. Since joining the company, Samir Rashmikant Patel has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 31, 2024 involved receiving (via award) 0 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| May 31, 2024 | AKTX | $0 | Award | 0 | $N/A | Discretionary |
Samir Rashmikant Patel currently holds 0 shares of Akari Therapeutics Plc (AKTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Samir Rashmikant Patel has been a net neutral trader of AKTX stock. They have purchased $0 and sold $0 worth of shares.
Samir Rashmikant Patel's most recent insider trade was on May 31, 2024, when they sold 0 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted